4basebio (4BB) Competitors GBX 1,260 -20.00 (-1.56%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider Trades 4BB vs. SLN, OXB, PRTC, HZD, VRP, AVCT, HVO, BVXP, ARIX, and FARNShould you be buying 4basebio stock or one of its competitors? The main competitors of 4basebio include Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Avacta Group (AVCT), hVIVO (HVO), Bioventix (BVXP), Arix Bioscience (ARIX), and Faron Pharmaceuticals Oy (FARN). These companies are all part of the "biotechnology" industry. 4basebio vs. Silence Therapeutics Oxford Biomedica PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Avacta Group hVIVO Bioventix Arix Bioscience Faron Pharmaceuticals Oy 4basebio (LON:4BB) and Silence Therapeutics (LON:SLN) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, community ranking, profitability and media sentiment. Do institutionals & insiders hold more shares of 4BB or SLN? 2.0% of 4basebio shares are held by institutional investors. 68.4% of 4basebio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media favor 4BB or SLN? In the previous week, 4basebio and 4basebio both had 1 articles in the media. Silence Therapeutics' average media sentiment score of 1.02 beat 4basebio's score of 0.00 indicating that Silence Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 4basebio 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Silence Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer 4BB or SLN? Silence Therapeutics received 203 more outperform votes than 4basebio when rated by MarketBeat users. CompanyUnderperformOutperform4basebioN/AN/ASilence TherapeuticsOutperform Votes20368.81% Underperform Votes9231.19% Which has higher valuation and earnings, 4BB or SLN? Silence Therapeutics has higher revenue and earnings than 4basebio. 4basebio is trading at a lower price-to-earnings ratio than Silence Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio4basebio£311K518.99-£9.84M-£0.78-1,615.38Silence Therapeutics£11.35M42.34N/A-£48.60-11.01 Do analysts rate 4BB or SLN? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 4basebio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ASilence Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is 4BB or SLN more profitable? Silence Therapeutics' return on equity of 0.00% beat 4basebio's return on equity.Company Net Margins Return on Equity Return on Assets 4basebioN/A -231.29% -54.30% Silence Therapeutics N/A N/A N/A SummarySilence Therapeutics beats 4basebio on 6 of the 10 factors compared between the two stocks. Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Get 4basebio News Delivered to You Automatically Sign up to receive the latest news and ratings for 4BB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart 4BB vs. The Competition Export to ExcelMetric4basebioBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£161.41M£159.96M£5.39B£1.58BDividend YieldN/A3.39%5.13%11.03%P/E Ratio-1,615.38348.23113.811,730.79Price / Sales518.9919,593.141,483.25229,524.84Price / Cash16.0811.1439.6435.78Price / Book-30.737.754.662.87Net Income-£9.84M-£18.69M£119.06M£144.63M7 Day Performance-4.18%0.01%0.79%0.11%1 Month Performance-6.80%2.54%5.65%-0.11%1 Year Performance144.66%27.91%36.76%15.22% 4basebio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)4BB4basebioN/AGBX 1,260-1.6%N/A+158.0%£161.41M£311,000.00-1,615.38101News CoverageHigh Trading VolumeSLNSilence TherapeuticsN/AGBX 535-0.9%N/A+0.0%£480.35M£11.35M-11.01100Positive NewsHigh Trading VolumeOXBOxford Biomedica0.6228 of 5 starsGBX 405+1.8%GBX 433.33+7.0%+96.8%£426.71M£97.28M-281.25891News CoveragePRTCPureTech HealthN/AGBX 155.40+1.8%N/A+4.0%£372.06M£3.33M-675.65300Gap UpHZDHorizon Discovery Group plc (HZD.L)N/AGBX 184.50flatN/A+0.0%£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AGBX 55+5.8%N/A+0.0%£228MN/A-1.6822News CoverageGap UpAVCTAvacta GroupN/AGBX 54+8.0%N/A-62.2%£193.48M£22.62M-600.00120HVOhVIVON/AGBX 28.30-0.7%N/A+45.3%£192.55M£67.21M943.33N/APositive NewsBVXPBioventixN/AGBX 3,650flatN/A-0.8%£190.53M£13.60M2,239.2612Dividend IncreaseInsider BuyingNews CoveragePositive NewsARIXArix BioscienceN/AN/AN/A+21.9%£183.73M£14.16M1,290.919FARNFaron Pharmaceuticals OyN/AGBX 165flatN/A-34.4%£172.62M£-725,000.00-515.6334Gap Down Related Companies and Tools Related Companies Silence Therapeutics Competitors Oxford Biomedica Competitors PureTech Health Competitors Horizon Discovery Group plc (HZD.L) Competitors Verona Pharma plc (VRP.L) Competitors Avacta Group Competitors hVIVO Competitors Bioventix Competitors Arix Bioscience Competitors Faron Pharmaceuticals Oy Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:4BB) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4basebio PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share 4basebio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
